Long non-coding RNA BST2/BISPR is induced by IFN and regulates the expression of the antiviral factor Tetherin

Frontiers in Immunology

Volumn 5, Issue DEC, 2014, Pages

  Barriocanal, Marina ^a   Carnero, Elena ^a   Segura, Victor ^a   Fortes, Puri ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

BST2; HCV; IFN; ISG15; LncRNAs; Tetherin

Indexed keywords

ALPHA2 INTERFERON; INTERFERON; LONG UNTRANSLATED RNA; PROTEIN; RUXOLITINIB; TETHERIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BIOINFORMATICS; CELL CULTURE; CELL FRACTIONATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLUENZA; INFLUENZA VIRUS; OPEN READING FRAME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; RNA SEQUENCE; SEMLIKI FOREST ALPHAVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 84919493875     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00655     Document Type: Article

References (109)

1. Ivashkiv LB and Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol (2014) 14: 36-49. doi:10.1038/nri3581.
2. Bolen CR, Ding S, Robek MD, Kleinstein SH. Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression. Hepatology (2014) 59: 1262-1272. doi:10.1002/hep.26657.
3. Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, MacDonald MR, et al. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology (2006) 131: 1887-1898. doi:S0016-5085(06)02220-7.
4. McLaren JE and Ramji DP. Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev (2009) 20: 125-135. doi:10.1016/j.cytogfr.2008.11.003.
5. Zaidi MR and Merlino G. The two faces of interferon-gamma in cancer. Clin Cancer Res (2011) 17: 6118-6124. doi:10.1158/1078-0432.CCR-11-0482.
6. van Boxel-Dezaire AH, Rani MR, Stark GR. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity (2006) 25: 361-372. doi:S1074- 7613(06)00399-2.
7. Qiao Y, Giannopoulou EG, Chan CH, Park SH, Gong S, Chen J, et al. Synergistic activation of inflammatory cytokine genes by interferon-gamma-induced chromatin remodeling and toll-like receptor signaling. Immunity (2013) 39: 454-469. doi:10.1016/j.immuni.2013.08.009.
8. Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol (2014) 32: 513-545. doi:10.1146/annurev-immunol- 032713-120231.
9. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol (2007) 7: 454-465. doi:nri2093.
10. Sarasin-Filipowicz M, Wang X, Yan M, Duong FH, Poli V, Hilton DJ, et al. Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43. Mol Cell Biol (2009) 29: 4841-4851. doi:10.1128/MCB.00224-09.
11. Hertzog PJ and Williams BR. Fine tuning type I interferon responses. Cytokine Growth Factor Rev (2013) 24: 217-225. doi:10.1016/j.cytogfr.2013.04.002.
12. David M. Interferons and microRNAs. J Interferon Cytokine Res (2010) 30: 825-828. doi:10.1089/jir.2010.0080.
13. Josset L, Tchitchek N, Gralinski LE, Ferris MT, Eisfeld AJ, Green RR, et al. Annotation of long non-coding RNAs expressed in Collaborative Cross founder mice in response to respiratory virus infection reveals a new class of interferon-stimulated transcripts. RNA Biol (2014) 11 doi:29442.
14. Kambara H, Niazi F, Kostadinova L, Moonka DK, Siegel CT, Post AB, et al. Negative regulation of the interferon response by an interferon-induced long non-coding RNA. Nucleic Acids Res (2014).
15. Carnero E, Barriocanal M, Segura V, Guruceaga E, Prior C, Börner K, et al. Type Interferon Regulates the Expression of Long Noncoding RNAs. Front Immunol (2014) 5 doi:10.3389/fimmu.2014.00548.
16. Yin Z, Guan D, Fan Q, Su J, Zheng W, Ma W, et al. lncRNA expression signatures in response to enterovirus 71 infection. Biochem Biophys Res Commun (2013) 430: 629-633. doi:10.1016/j.bbrc.2012.11.101.
17. Winterling C, Koch M, Koeppel M, Garcia-Alcalde F, Karlas A, Meyer TF. Evidence for a crucial role of a host non-coding RNA in influenza A virus replication. RNA Biol (2014) 11: 66-75. doi:10.4161/rna.27504.
18. Peng X, Gralinski L, Armour CD, Ferris MT, Thomas MJ, Proll S, et al. Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling. MBio (2010) 1: 10.1128/mBio.00206-10. doi:10.1128/mBio.00206-10 [doi].
19. Imamura K, Imamachi N, Akizuki G, Kumakura M, Kawaguchi A, Nagata K, et al. Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol Cell (2014) 53: 393-406. doi:10.1016/j.molcel.2014.01.009.
20. Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang Y, Tang GN, et al. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology (2013) 57: 1882-1892. doi:10.1002/hep.26195.
21. Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology (2011) 54: 1679-1689. doi:10.1002/hep.24563.
22. Du Y, Kong G, You X, Zhang S, Zhang T, Gao Y, et al. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem (2012) 287: 26302-26311. doi:10.1074/jbc.M112.342113.
23. Zhang Q, Chen CY, Yedavalli VS, Jeang KT. NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. MBio (2013) 4: e00596-12. doi:10.1128/mBio.00596-12.
24. Carpenter S, Aiello D, Atianand MK, Ricci EP, Gandhi P, Hall LL, et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science (2013) 341: 789-792. doi:10.1126/science.1240925.
25. IIott NE, Heward JA, Roux B, Tsitsiou E, Fenwick PS, Lenzi L, et al. Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes. Nat Commun (2014) 5: 3979. doi:10.1038/ncomms4979.
26. Cui H, Xie N, Tan Z, Banerjee S, Thannickal VJ, Abraham E, et al. The human long noncoding RNA lnc-IL7R regulates the inflammatory response. Eur J Immunol (2014) doi:10.1002/eji.201344126.
27. Li Z, Chao TC, Chang KY, Lin N, Patil VS, Shimizu C, et al. The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A (2014) 111: 1002-1007. doi:10.1073/pnas.1313768111.
28. Rapicavoli NA, Qu K, Zhang J, Mikhail M, Laberge RM, Chang HY. A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. Elife (2013) 2: e00762. doi:10.7554/eLife.00762.
29. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 458: 223-227. doi:10.1038/nature07672.
30. Pang KC, Dinger ME, Mercer TR, Malquori L, Grimmond SM, Chen W, et al. Genomewide identification of long noncoding RNAs in CD8+ T cells. J Immunol (2009) 182: 7738-7748. doi:10.4049/jimmunol.0900603.
31. Pagani M, Rossetti G, Panzeri I, de Candia P, Bonnal RJ, Rossi RL, et al. Role of microRNAs and long-non-coding RNAs in CD4(+) T-cell differentiation. Immunol Rev (2013) 253: 82-96. doi:10.1111/imr.12055.
32. Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S, et al. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science (2014) 344: 310-313. doi:10.1126/science.1251456.
33. Gomez JA, Wapinski OL, Yang YW, Bureau JF, Gopinath S, Monack DM, et al. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferongamma locus. Cell (2013) 152: 743-754. doi:10.1016/j.cell.2013.01.015.
34. Collier SP, Collins PL, Williams CL, Boothby MR, Aune TM. Cutting edge: influence of Tmevpg1, a long intergenic noncoding RNA, on the expression of Ifng by Th1 cells. J Immunol (2012) 189: 2084-2088. doi:10.4049/jimmunol.1200774.
35. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 489: 57-74. doi:10.1038/nature11247.
36. Morris KV and Mattick JS. The rise of regulatory RNA. Nat Rev Genet (2014) 15: 423-437. doi:10.1038/nrg3722.
37. Gibb EA, Vucic EA, Enfield KS, Stewart GL, Lonergan KM, Kennett JY, et al. Human cancer long non-coding RNA transcriptomes. PLoS One (2011) 6: e25915. doi:10.1371/journal.pone.0025915.
38. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A (2008) 105: 716-721. doi:10.1073/pnas.0706729105.
39. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature (2012) 489: 101-108. doi:10.1038/nature11233.
40. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell (2010) 38: 662-674. doi:10.1016/j.molcel.2010.03.021.
41. Allo M, Buggiano V, Fededa JP, Petrillo E, Schor I, de la Mata M, et al. Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat Struct Mol Biol (2009) 16: 717-724. doi:10.1038/nsmb.1620.
42. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med (2008) 14: 723-730. doi:10.1038/nm1784.
43. Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP, et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature (2008) 451: 202-206. doi:10.1038/nature06468.
44. Yang L, Froberg JE, Lee JT. Long noncoding RNAs: fresh perspectives into the RNA world. Trends Biochem Sci (2014) 39: 35-43. doi:10.1016/j.tibs.2013.10.002.
45. Ichihara M, Murakumo Y, Masuda A, Matsuura T, Asai N, Jijiwa M, et al. Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activities. Nucleic Acids Res (2007) 35: e123. doi:gkm699.
46. Matveeva O, Nechipurenko Y, Rossi L, Moore B, Saetrom P, Ogurtsov AY, et al. Comparison of approaches for rational siRNA design leading to a new efficient and transparent method. Nucleic Acids Res (2007) 35: e63. doi:gkm088.
47. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med (2005) 11: 791-796. doi:nm1268.
48. Aparicio O, Carnero E, Abad X, Razquin N, Guruceaga E, Segura V, et al. Adenovirus VA RNA-derived miRNAs target cellular genes involved in cell growth, gene expression and DNA repair. Nucleic Acids Res (2010) 38: 750-763. doi:10.1093/nar/gkp1028.
49. Garcia-Sastre A. Induction and evasion of type I interferon responses by influenza viruses. Virus Res (2011) 162: 12-18. doi:10.1016/j.virusres.2011.10.017.
50. Ferran MC and Lucas-Lenard JM. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J Virol (1997) 71: 371-377.
51. Narvaiza I, Aparicio O, Vera M, Razquin N, Bortolanza S, Prieto J, et al. Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing. J Virol (2006) 80: 12236-12247. doi:JVI.01205-06.
52. Abad X, Razquin N, Abad A, Fortes P. Combination of RNA interference and U1 inhibition leads to increased inhibition of gene expression. Nucleic Acids Res (2010) 38: e136. doi:10.1093/nar/gkq299.
53. Blazquez L, Gonzalez-Rojas SJ, Abad A, Razquin N, Abad X, Fortes P. Increased in vivo inhibition of gene expression by combining RNA interference and U1 inhibition. Nucleic Acids Res (2012) 40: e8. doi:10.1093/nar/gkr956.
54. Sobrevals L, Enguita M, Rodriguez C, Gonzalez-Rojas J, Alzaguren P, Razquin N, et al. AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers. Gene Ther (2012) 19: 411-417. doi:10.1038/gt.2011.119.
55. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol (2013) 14: R36. doi:gb-2013-14-4-r36.
56. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol (2010) 28: 511-515. doi:10.1038/nbt.1621.
57. Gentleman R, Carey V, Huber W, Irizarry R and Dudoit S(). Bioinformatics and Computational Biology Solutions Using R and Bioconductor.: Springer, New York, N.Y.
58. Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): highperformance genomics data visualization and exploration. Brief Bioinform (2013) 14: 178-178-192. doi:10.1093/bib/bbs017.
59. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol (2011) 29: 24-26. doi:10.1038/nbt.1754.
60. Karolchik D, Barber GP, Casper J, Clawson H, Cline MS, Diekhans M, et al. The UCSC Genome Browser database: 2014 update. Nucleic Acids Res (2014) 42: D764-70. doi:10.1093/nar/gkt1168.
61. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res (2012) 22: 1760-1774. doi:10.1101/gr.135350.111.
62. Draghici S. Data analysis tools for DNA microarrays.: Boca Raton [etc.] :Chapman & Hall/CRC (2003).
63. Kong L, Zhang Y, Ye ZQ, Liu XQ, Zhao SQ, Wei L, et al. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res (2007) 35: W345-9. doi:35/suppl_2/W345.
64. Wang L, Park HJ, Dasari S, Wang S, Kocher JP, Li W. CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res (2013) 41: e74. doi:10.1093/nar/gkt006.
65. Volders PJ, Helsens K, Wang X, Menten B, Martens L, Gevaert K, et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res (2013) 41: D246-51. doi:10.1093/nar/gks915.
66. Vizcaino JA, Cote RG, Csordas A, Dianes JA, Fabregat A, Foster JM, et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res (2013) 41: D1063-9. doi:10.1093/nar/gks1262.
67. Lee S, Liu B, Lee S, Huang SX, Shen B, Qian SB. Global mapping of translation initiation sites in mammalian cells at single-nucleotide resolution. Proc Natl Acad Sci U S A (2012) 109: E2424-32. doi:10.1073/pnas.1207846109.
68. Bazzini AA, Johnstone TG, Christiano R, Mackowiak SD, Obermayer B, Fleming ES, et al. Identification of small ORFs in vertebrates using ribosome footprinting and evolutionary conservation. EMBO J (2014) 33: 981-993. doi:10.1002/embj.201488411.
69. Lin MF, Carlson JW, Crosby MA, Matthews BB, Yu C, Park S, et al. Revisiting the proteincoding gene catalog of Drosophila melanogaster using 12 fly genomes. Genome Res (2007) 17: 1823-1836. doi:gr.6679507.
70. Francois C, Bernard I, Castelain S, Charleston B, Fray MD, Capiod JC, et al. Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation. Antimicrob Agents Chemother (2005) 49: 3770-3775. doi:49/9/3770.
71. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology (1998) 252: 324-330. doi:S0042682298995083.
72. Basu M, Maitra RK, Xiang Y, Meng X, Banerjee AK, Bose S. Inhibition of vesicular stomatitis virus infection in epithelial cells by alpha interferon-induced soluble secreted proteins. J Gen Virol (2006) 87: 2653-2662. doi:87/9/2653.
73. Trinklein ND, Aldred SF, Hartman SJ, Schroeder DI, Otillar RP, Myers RM. An abundance of bidirectional promoters in the human genome. Genome Res (2004) 14: 62-66. doi:10.1101/gr.1982804.
74. Engstrom PG, Suzuki H, Ninomiya N, Akalin A, Sessa L, Lavorgna G, et al. Complex Loci in human and mouse genomes. PLoS Genet (2006) 2: e47. doi:10.1371/journal.pgen.0020047.
75. Au WC, Moore PA, Lowther W, Juang YT, Pitha PM. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci U S A (1995) 92: 11657-11661.
76. Black MB, Parks BB, Pluta L, Chu TM, Allen BC, Wolfinger RD, et al. Comparison of microarrays and RNA-seq for gene expression analyses of dose-response experiments. Toxicol Sci (2014) 137: 385-403. doi:10.1093/toxsci/kft249.
77. Guo Y, Sheng Q, Li J, Ye F, Samuels DC, Shyr Y. Large scale comparison of gene expression levels by microarrays and RNAseq using TCGA data. PLoS One (2013) 8: e71462. doi:10.1371/journal.pone.0071462.
78. Lin JM, Collins PJ, Trinklein ND, Fu Y, Xi H, Myers RM, et al. Transcription factor binding and modified histones in human bidirectional promoters. Genome Res (2007) 17: 818-827. doi:17/6/818.
79. Li YY, Yu H, Guo ZM, Guo TQ, Tu K, Li YX. Systematic analysis of head-to-head gene organization: evolutionary conservation and potential biological relevance. PLoS Comput Biol (2006) 2: e74. doi:05-PLCB-RA-0340R2.
80. Adachi N and Lieber MR. Bidirectional gene organization: a common architectural feature of the human genome. Cell (2002) 109: 807-809. doi:S0092867402007584.
81. Guarguaglini G, Battistoni A, Pittoggi C, Di Matteo G, Di Fiore B, Lavia P. Expression of the murine RanBP1 and Htf9-c genes is regulated from a shared bidirectional promoter during cell cycle progression. Biochem J (1997) 325 ( Pt 1): 277-286.
82. Lepoivre C, Belhocine M, Bergon A, Griffon A, Yammine M, Vanhille L, et al. Divergent transcription is associated with promoters of transcriptional regulators. BMC Genomics (2013) 14: 914-2164-14-914. doi:10.1186/1471-2164-14-914.
83. Wei W, Pelechano V, Jarvelin AI, Steinmetz LM. Functional consequences of bidirectional promoters. Trends Genet (2011) 27: 267-276. doi:10.1016/j.tig.2011.04.002.
84. Wang X, Arai S, Song X, Reichart D, Du K, Pascual G, et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature (2008) 454: 126-130. doi:10.1038/nature06992.
85. Xu Z, Wei W, Gagneur J, Clauder-Munster S, Smolik M, Huber W, et al. Antisense expression increases gene expression variability and locus interdependency. Mol Syst Biol (2011) 7: 468. doi:10.1038/msb.2011.1.
86. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, Johnson MC, et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell (2009) 139: 499-511. doi:10.1016/j.cell.2009.08.039.
87. Swiecki M, Omattage NS, Brett TJ. BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor. Mol Immunol (2013) 54: 132-139. doi:10.1016/j.molimm.2012.11.008.
88. Blanco-Melo D, Venkatesh S, Bieniasz PD. Intrinsic cellular defenses against human immunodeficiency viruses. Immunity (2012) 37: 399-411. doi:10.1016/j.immuni.2012.08.013.
89. Amet T, Byrd D, Hu N, Sun Q, Li F, Zhao Y, et al. BST-2 expression in human hepatocytes is inducible by all three types of interferons and restricts production of hepatitis C virus. Curr Mol Med (2014) 14: 349-360. doi:CMM-EPUB-57456.
90. Venkatesh S and Bieniasz PD. Mechanism of HIV-1 virion entrapment by tetherin. PLoS Pathog (2013) 9: e1003483. doi:10.1371/journal.ppat.1003483.
91. Pan XB, Qu XW, Jiang D, Zhao XL, Han JC, Wei L. BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells. Antiviral Res (2013) 98: 54-60. doi:10.1016/j.antiviral.2013.01.009.
92. McNatt MW, Zang T, Bieniasz PD. Vpu binds directly to tetherin and displaces it from nascent virions. PLoS Pathog (2013) 9: e1003299. doi:10.1371/journal.ppat.1003299.
93. Mangeat B, Cavagliotti L, Lehmann M, Gers-Huber G, Kaur I, Thomas Y, et al. Influenza virus partially counteracts restriction imposed by tetherin/BST-2. J Biol Chem (2012) 287: 22015-22029. doi:10.1074/jbc.M111.319996.
94. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV- 1 Vpu. Nature (2008) 451: 425-430. doi:10.1038/nature06553.
95. Weidner JM, Jiang D, Pan XB, Chang J, Block TM, Guo JT. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol (2010) 84: 12646-12657. doi:10.1128/JVI.01328-10.
96. Horner SM and Gale M,Jr. Regulation of hepatic innate immunity by hepatitis C virus. Nat Med (2013) 19: 879-888. doi:10.1038/nm.3253.
97. Mihm S, Frese M, Meier V, Wietzke-Braun P, Scharf JG, Bartenschlager R, et al. Interferon type I gene expression in chronic hepatitis C. Lab Invest (2004) 84: 1148-1159. doi:10.1038/labinvest.3700135.
98. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, Christen V, Terracciano L, Filipowicz W, et al. Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A (2008) 105: 7034-7039. doi:10.1073/pnas.0707882105.
99. Bigger CB, Guerra B, Brasky KM, Hubbard G, Beard MR, Luxon BA, et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol (2004) 78: 13779-13792. doi:78/24/13779.
100. Arnaud N, Dabo S, Maillard P, Budkowska A, Kalliampakou KI, Mavromara P, et al. Hepatitis C virus controls interferon production through PKR activation. PLoS One (2010) 5: e10575. doi:10.1371/journal.pone.0010575.
101. Garaigorta U and Chisari FV. Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe (2009) 6: 513-522. doi:10.1016/j.chom.2009.11.004.
102. Zhao C, Collins MN, Hsiang TY, Krug RM. Interferon-induced ISG15 pathway: an ongoing virus-host battle. Trends Microbiol (2013) 21: 181-186. doi:10.1016/j.tim.2013.01.005.
103. Morales DJ and Lenschow DJ. The antiviral activities of ISG15. J Mol Biol (2013) 425: 4995-5008. doi:10.1016/j.jmb.2013.09.041.
104. Shi HX, Yang K, Liu X, Liu XY, Wei B, Shan YF, et al. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol (2010) 30: 2424-2436. doi:10.1128/MCB.01466-09.
105. Broering R, Zhang X, Kottilil S, Trippler M, Jiang M, Lu M, et al. The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response. Gut (2010) 59: 1111-1119. doi:10.1136/gut.2009.195545.
106. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, et al. IFNstimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A (2007) 104: 1371-1376. doi:0607038104.
107. Chen L, Sun J, Meng L, Heathcote J, Edwards AM, McGilvray ID. ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment. J Gen Virol (2010) 91: 382-388. doi:10.1099/vir.0.015388-0.
108. Kim MJ, Hwang SY, Imaizumi T, Yoo JY. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol (2008) 82: 1474-1483. doi:JVI.01650-07.
109. Helbig KJ, Eyre NS, Yip E, Narayana S, Li K, Fiches G, et al. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology (2011) 54: 1506-1517. doi:10.1002/hep.24542.